Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical studies on interaction of STI-571 with chemotherapeutic agents and radiation

Jan. 3, 2001

BLA for Zevalin granted priority review by FDA

Jan. 3, 2001

Genta licenses technology platform for designing novel anticancer treatments

Jan. 3, 2001

Bioniche bladder cancer trial yields positive interim results

Jan. 3, 2001

Enhanced version of MetXia to be codeveloped by Oxford BioMedica and PolyMASC

Jan. 3, 2001

Clinical trial commences for new antiangiogenic agent discovered by OSI and Pfizer

Jan. 2, 2001

BresaGen's lead anticancer compound E21R licensed to British Biotech

Jan. 2, 2001

Enzon seeks FDA approval to clinically evaluate PEG-paclitaxel

Jan. 2, 2001

Neovastat pivotal trial for third cancer indication approved in U.S. and Canada

Jan. 2, 2001

Gilead's NX-211 enters phase II for second cancer indication

Dec. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...